Cme Group Depreciation & Amortization Growth & History (CME)
Cme Group's depreciation and amortization was $107.5M for fiscal 2025.
View full Cme Group company overviewCme Group annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $107.5M | −$7.6M | −6.60% |
| 2024 | 2024-12-31 | $115.1M | −$10.9M | −8.65% |
| 2023 | 2023-12-31 | $126.0M | −$8.9M | −6.60% |
| 2022 | 2022-12-31 | $134.9M | −$12.9M | −8.73% |
| 2021 | 2021-12-31 | $147.8M | −$5.4M | −3.52% |
| 2020 | 2020-12-31 | $153.2M | −$5.4M | −3.40% |
| 2019 | 2019-12-31 | $158.6M | $39.9M | +33.61% |
| 2018 | 2018-12-31 | $118.7M | $5.7M | +5.04% |
| 2017 | 2017-12-31 | $113.0M | −$16.2M | −12.54% |
| 2016 | 2016-12-31 | $129.2M | $0 | 0.00% |
| 2015 | 2015-12-31 | $129.2M | −$3.4M | −2.56% |
| 2014 | 2014-12-31 | $132.6M | −$2.5M | −1.85% |
| 2013 | 2013-12-31 | $135.1M | −$1.8M | −1.31% |
| 2012 | 2012-12-31 | $136.9M | $8.4M | +6.54% |
| 2011 | 2011-12-31 | $128.5M | −$1.4M | −1.08% |
| 2010 | 2010-12-31 | $129.9M | $3.6M | +2.85% |
| 2009 | 2009-12-31 | $126.3M | −$11.0M | −8.01% |
| 2008 | 2008-12-31 | $137.3M | $31.6M | +29.90% |
| 2007 | 2007-12-31 | $105.7M | — | — |
Cme Group quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $84.2M | $800,000 | +0.96% |
| Q1 2026 | 2026-03-31 | $83.3M | $800,000 | +0.97% |
| Q4 2025 | 2025-12-31 | $82.4M | — | — |
| Q3 2025 | 2025-09-30 | $82.6M | −$1.3M | −1.55% |
| Q2 2025 | 2025-06-30 | $83.4M | −$800,000 | −0.95% |
| Q1 2025 | 2025-03-31 | $82.5M | −$2.8M | −3.28% |
| Q3 2024 | 2024-09-30 | $83.9M | −$4.4M | −4.98% |
| Q2 2024 | 2024-06-30 | $84.2M | −$5.1M | −5.71% |
| Q1 2024 | 2024-03-31 | $85.3M | −$3.4M | −3.83% |
| Q3 2023 | 2023-09-30 | $88.3M | −$1.7M | −1.89% |
| Q2 2023 | 2023-06-30 | $89.3M | −$800,000 | −0.89% |
| Q1 2023 | 2023-03-31 | $88.7M | −$3.2M | −3.48% |
| Q3 2022 | 2022-09-30 | $90.0M | −$6.2M | −6.44% |
| Q2 2022 | 2022-06-30 | $90.1M | −$6.4M | −6.63% |
| Q1 2022 | 2022-03-31 | $91.9M | −$6.3M | −6.42% |
| Q3 2021 | 2021-09-30 | $96.2M | −$21.8M | −18.47% |
| Q2 2021 | 2021-06-30 | $96.5M | −$16.8M | −14.83% |
| Q1 2021 | 2021-03-31 | $98.2M | −$14.4M | −12.79% |
| Q3 2020 | 2020-09-30 | $118.0M | $76.6M | +185.02% |
| Q2 2020 | 2020-06-30 | $113.3M | $67.0M | +144.71% |
| Q1 2020 | 2020-03-31 | $112.6M | $79.7M | +242.25% |
| Q3 2019 | 2019-09-30 | $41.4M | $11.2M | +37.09% |
| Q2 2019 | 2019-06-30 | $46.3M | $18.8M | +68.36% |
| Q1 2019 | 2019-03-31 | $32.9M | $4.8M | +17.08% |
| Q3 2018 | 2018-09-30 | $30.2M | $3.3M | +12.27% |
| Q2 2018 | 2018-06-30 | $27.5M | −$1.3M | −4.51% |
| Q1 2018 | 2018-03-31 | $28.1M | −$1.3M | −4.42% |
| Q3 2017 | 2017-09-30 | $26.9M | −$4.3M | −13.78% |
| Q2 2017 | 2017-06-30 | $28.8M | −$1.6M | −5.26% |
| Q1 2017 | 2017-03-31 | $29.4M | −$4.5M | −13.27% |
| Q3 2016 | 2016-09-30 | $31.2M | −$1.2M | −3.70% |
| Q2 2016 | 2016-06-30 | $30.4M | −$2.9M | −8.71% |
| Q1 2016 | 2016-03-31 | $33.9M | $2.1M | +6.60% |
| Q3 2015 | 2015-09-30 | $32.4M | −$300,000 | −0.92% |
| Q2 2015 | 2015-06-30 | $33.3M | −$1.0M | −2.92% |
| Q1 2015 | 2015-03-31 | $31.8M | −$2.3M | −6.74% |
| Q3 2014 | 2014-09-30 | $32.7M | −$2.3M | −6.57% |
| Q2 2014 | 2014-06-30 | $34.3M | $1.1M | +3.31% |
| Q1 2014 | 2014-03-31 | $34.1M | $1.5M | +4.60% |
| Q3 2013 | 2013-09-30 | $35.0M | $500,000 | +1.45% |
| Q2 2013 | 2013-06-30 | $33.2M | −$400,000 | −1.19% |
| Q1 2013 | 2013-03-31 | $32.6M | −$2.3M | −6.59% |
| Q3 2012 | 2012-09-30 | $34.5M | $2.1M | +6.48% |
| Q2 2012 | 2012-06-30 | $33.6M | $1.9M | +5.99% |
| Q1 2012 | 2012-03-31 | $34.9M | $3.9M | +12.58% |
| Q3 2011 | 2011-09-30 | $32.4M | −$700,000 | −2.11% |
| Q2 2011 | 2011-06-30 | $31.7M | −$1.1M | −3.35% |
| Q1 2011 | 2011-03-31 | $31.0M | −$1.2M | −3.73% |
| Q3 2010 | 2010-09-30 | $33.1M | $800,000 | +2.48% |
| Q2 2010 | 2010-06-30 | $32.8M | $2.7M | +8.97% |
| Q1 2010 | 2010-03-31 | $32.2M | $1.2M | +3.87% |
| Q3 2009 | 2009-09-30 | $32.3M | −$1.8M | −5.28% |
| Q2 2009 | 2009-06-30 | $30.1M | −$4.4M | −12.75% |
| Q1 2009 | 2009-03-31 | $31.0M | — | — |
| Q3 2008 | 2008-09-30 | $34.1M | — | — |
| Q2 2008 | 2008-06-30 | $34.5M | — | — |
Cme Group depreciation and amortization trends
Over the last five fiscal years, Cme Group's depreciation and amortization decreased from $153.2M to $107.5M, a change of −$45.7M. The latest reported quarter, Q2 2026, shows $84.2M.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cme Group source filings ↗Community posts
CME plans European dairy futures and options through EEX transition
CME Group ($CME) agreed with the European Energy Exchange to transition EEX’s European dairy business, including its butter and skimmed-milk-powder indices, as EEX phases out those products. CME plans to establish its own European dairy ind ...
CME sets an FX open-interest record of 4.41 million contracts
CME Group reported a new foreign-exchange derivatives milestone on 7 September 2026. Reported records FX futures and options open interest reached 4,410,167 contracts on 4 September, exceeding the previous 4,269,622 record from 11 June. Tha ...